FFA
MBOT icon

Farther Finance Advisors’s Microbot Medical MBOT Stock Holding History

Farther Finance Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
1
– – ﹤0.01% 5960
2026
Q1 		$2 Buy
+1
New +$2 ﹤0.01% 5732

Other funds holding MBOT

AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
API
Asset Planning Inc Cypress, California $154M AUM 25.18% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Farther Finance Advisors's MBOT Position: Q2 2026 in Review

Farther Finance Advisors held its Microbot Medical (MBOT) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #5960.

Farther Finance Advisors first reported a position in MBOT in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Farther Finance Advisors held 1 share of Microbot Medical worth $2 as of Q2 2026.
  • Farther Finance Advisors left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5960 holding.
  • Farther Finance Advisors first reported a position in Microbot Medical in Q1 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.